Shandong Shanda Wit Science and Technology Co Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more
Shandong Shanda Wit Science and Technology Co Ltd (000915) - Total Liabilities
Latest total liabilities as of September 2025: CN¥573.21 Million CNY
Based on the latest financial reports, Shandong Shanda Wit Science and Technology Co Ltd (000915) has total liabilities worth CN¥573.21 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shandong Shanda Wit Science and Technology Co Ltd - Total Liabilities Trend (1996–2024)
This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shandong Shanda Wit Science and Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Shanda Wit Science and Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Megaport Ltd
AU:MP1
|
Australia | AU$81.52 Million |
|
Fengzhushou Co. Ltd. A
SHE:301382
|
China | CN¥1.18 Billion |
|
Inwido AB
ST:INWI
|
Sweden | Skr5.08 Billion |
|
Quanex Building Products
NYSE:NX
|
USA | $1.25 Billion |
|
Lotte Tour Dev
KO:032350
|
Korea | ₩1.85 Trillion |
|
ZINKA LOGISTICS SOL LTD
NSE:BLACKBUCK
|
India | ₹2.54 Billion |
|
Luxin Venture Capital Group Co Ltd
SHG:600783
|
China | CN¥4.54 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥11.73 Billion |
Liability Composition Analysis (1996–2024)
This chart breaks down Shandong Shanda Wit Science and Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Shanda Wit Science and Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Shanda Wit Science and Technology Co Ltd (1996–2024)
The table below shows the annual total liabilities of Shandong Shanda Wit Science and Technology Co Ltd from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥518.50 Million | -26.10% |
| 2023-12-31 | CN¥701.65 Million | +11.55% |
| 2022-12-31 | CN¥629.03 Million | +17.35% |
| 2021-12-31 | CN¥536.03 Million | -29.44% |
| 2020-12-31 | CN¥759.72 Million | +29.80% |
| 2019-12-31 | CN¥585.32 Million | +4.72% |
| 2018-12-31 | CN¥558.92 Million | +0.46% |
| 2017-12-31 | CN¥556.37 Million | +4.40% |
| 2016-12-31 | CN¥532.89 Million | +32.78% |
| 2015-12-31 | CN¥401.35 Million | -15.04% |
| 2014-12-31 | CN¥472.42 Million | +9.45% |
| 2013-12-31 | CN¥431.63 Million | +9.04% |
| 2012-12-31 | CN¥395.83 Million | +1.41% |
| 2011-12-31 | CN¥390.33 Million | -20.16% |
| 2010-12-31 | CN¥488.86 Million | -16.15% |
| 2009-12-31 | CN¥582.99 Million | -2.32% |
| 2008-12-31 | CN¥596.85 Million | -0.48% |
| 2007-12-31 | CN¥599.73 Million | +5.09% |
| 2006-12-31 | CN¥570.70 Million | -6.24% |
| 2005-12-31 | CN¥608.70 Million | +36.78% |
| 2004-12-31 | CN¥445.01 Million | +7.12% |
| 2003-12-31 | CN¥415.43 Million | +34.86% |
| 2002-12-31 | CN¥308.04 Million | +29.02% |
| 2001-12-31 | CN¥238.76 Million | +69.51% |
| 2000-12-31 | CN¥140.86 Million | +31.26% |
| 1999-12-31 | CN¥107.31 Million | -7.75% |
| 1998-12-31 | CN¥116.33 Million | -1.98% |
| 1997-12-31 | CN¥118.68 Million | +2.51% |
| 1996-12-31 | CN¥115.78 Million | -- |